30 -4 (36) 2021 — Ismatova Mehriniso Nasritdinovna — CHANGE OF THE PLATE RING OF HEMOSTASIS IN METABOLISM SYNDROME

CHANGE OF THE PLATE RING OF HEMOSTASIS IN METABOLISM SYNDROME

Ismatova Mehriniso Nasritdinovna Bukhara State Medical Institute, Bukhara, Uzbekistan

Resume

Metabolic syndrome, being a clinical example of comorbidity, refers to the clusters of risk factors for cardiovascular collapse. Purpose of the work: To study the significance of insulin resistance syndrome in the formation of pathology of the platelet hemostasis. The object of the study is 110 patients with metabolic syndrome. As comparison groups, 2 groups will be defined (one – persons without insulin resistance syndrome, the second group – patients with type 2 diabetes mellitus). The development of new methods for the prevention and treatment of platelet hemostasis disorders allows achieving economic efficiency due to the reduction of hospital beds, as well as medical efficiency due to the minimum morbidity, disability and mortality of the population.

Key words: metabolic syndrome, insulin resistance, hemostasis.

First page

146

Last page

149

For citation: Ismatova Mehriniso Nasritdinovna CHANGE OF THE PLATE RING OF HEMOSTASIS IN METABOLISM SYNDROME //New Day in Medicine 4(36)2021 146-149 https://cutt.ly/MTnIzqG

LIST OF REFERENCES:

1. Akhmedova N.SH. Otsenka funktsional’nogo sostoyaniya pochek u patsiyentov s izbytochnoy massy tela i ozhireniyem //Biologiya va tibbiyot muammolari.  Samarkand, 2018. – №4 (104). – S.15-18.
2. Akhmedova N.Sh., Khamidova N.K. Osobennosti i podkhody k lecheniyu giprelipidemii pri razlichnykh klinicheskikh formakh glomerulonefrita // Infektsiya, immunitet i farmakologiya. – Tashkent, 2017. – №2.  243-246
3. Ismatova M.N. i dr. Dinamika urovney komponentov metabolicheskogo sindroma pri razlichnykh vidakh giperglikemii // Journal of Biomedicine And Practice 2019 vol1-c 23-28
4. Kondrat’yeva Ye.I., Sukhanova G.A., Litvinova L.S. [i dr.] Vliyaniye vozrasta i pola na pokazateli koagulyatsionnogo i sosudisto-trombotsitarnogo gemostaza u bol’nykh sakharnogo diabeta 2 tipa // Klin. lab. diagnostika. — 2011. — № 8. — S. 41–43.
5. Lapina I.A., Chirvon T.G., Dobrokhotova Yu.E., Taranov V.V. Sovremennyye aspekty pregravidarnoy podgotovki u patsiyentok s sindromom polikistoznykh yaichnikov i metabolicheskim sindromom. RMZH. Mat’ i ditya. 2021;4(2):137-143. DOI: 10.32364/2618-8430-2021-4-2-137-143.
6. Makhmudova L.I., Akhmedova N.Sh. Sostoyaniye  trombotsitarnogo komponenta gemostaza u bol’nykh s khronicheskimi porazheniyami pochek// Infektsiya, immunitet i farmakologiya № 1/2015,str 19-23
7. Akhmedova N.Sh, Khamdamov I.I. Overweight as a risk factor for chronic kidney disease and its modern approach to early diagnosis // International Scientific and Practical CONFERENCE Trends in Science and Technology.–  Warsaw,  Poland, 2018. – Vol.3.– Р 34-36
8. Ismatova M.N., Nurullaeva D Features of pathogenesis and correcsion of anemia indused by antiviral therapy for hepatits C// The American Journal of Medical Sciences and Farmaceutical Research 2021/3/14/ 206-210
9. Kayumov U.K., A.D.Makhmudova Ismatova M.N . State of the hemostatic system in various components of the metabolic syndrome// International Journal of Scientific & Engineering Research Volume 10, Issue 11, 2020
10. Kayumov U., Kalandarova U., Ibadova M., Saipova M. Association of asymptomatic hyperuricemia with some components of metabolic syndrome and coronary heart disease // Eurasian Bulletin of Pediatrics. — Tashkent, 2019. — No. 3 (3) — R. 155-161.